Hao Wang

Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View

Shi Hu, Shuaiyi Liang, Huaizu Guo et al. · Journal of Biological Chemistry · 2013 · 150 citations · Full text

Toll-like receptor 4 (TLR4) deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating IL6, CCL2 and CSF3

Yun‐Jie Shi, Shijie Hu, Quanquan Zhao et al. · Annals of Translational Medicine · 2019 · 61 citations · Full text

Regulation of platelet-activating factor receptor gene expression <i>in vivo</i> by endotoxin, platelet-activating factor and endogenous tumour necrosis factor

Hao Wang, Xiao‐Di Tan, Hong Chang et al. · Biochemical Journal · 1997 · 58 citations · Full text

PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

Jie Gao, Geng Kou, Hao Wang et al. · Breast Cancer Research and Treatment · 2008 · 54 citations

Nanomedicine, Breast Oncology, Protein Nanoparticles +10

Tim-3 on Peripheral CD4 ⁺ and CD8 ⁺ T Cells Is Involved in the Development of Glioma

Song Iy Han, Sizhe Feng, Lunshan Xu et al. · DNA and Cell Biology · 2014 · 53 citations